[1] He Z, Xia Y,Tang S,et al.Detection of occult tumor cells in regional lymph nodes is associated with poor survival in pN0 non-small cell lung cancer: a meta-analysis[J].J Thorac Dis,2016,8(3):375-385.
[2] Bhatia S, Pereira K, Mohan P,et al.Radiofrequency ablation in primary non-small cell lung cancer: What a radiologist needs to know[J].Indian J Radiol Imaging,2016,26(1):81-91.
[3] Crinò L, Weder W, van Meerbeeck J,et al. Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMOC linical Practice Guidelines for diagnosis, treatment and follow-up[J].Ann Oncol,2010,21 Suppl 5:v103-115.
[4] 蒲德利,廖江荣.射频消融联合化疗治疗周围型中晚期非小细胞肺癌疗效观察[J].介入放射学杂志,2013,22(02):129-132.
[5] Nair AG, Asnani HT, Mehta VC, et al. Tyrosine Kinase Inhibitors in the Treatment of Choroidal Metastases from Non-Small-Cell Lung Cancer: A Case Report and Review of Literature[J].Ocul Oncol Pathol,2017,3(1):28-33.
[6] 隋东江,海燕,李伟生, 等. 80例老年人非小细胞肺癌临床分析[J].医学临床研究, 2012 , 29 (7) :1250-1251.
[7] D'Amico TA.VATS lobectomy facilitates the delivery of adjuvant docetaxel-carboplatin chemotherapy in patients with non-small cell lung cancer[J].J Thorac Dis,2016,8(3):296-297.
[8] Sanborn RE, Ross HJ, Aung S, et al. A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage Ⅳ non-small cell lung cancer[J].J Immunother Cancer,2017,5(1):103. |
2020, Vol. 37 
